Knome turns to China for genome sequencing

Knome turns to China for genome sequencing

(UPDATED: See below.)

Knome, the Cambridge, Mass., startup that will sequence the entire genomes of 20 customers for $350,000 apiece, launched its business back in November without ever explaining exactly how it planned to carry out the heavy lifting of whole-genome sequencing. At the time, CEO and… Continue Reading

The nitty-gritty on Knome: How it works

The nitty-gritty on Knome: How it works

(UPDATED: See below.)

(NOTE: This is the second of two posts on Knome, a newly launched startup that offers to sequence your entire genome for $350,000. For part one, which provides a broad overview of Knome’s whole-genome sequencing and how it differs from services offered by other personal-genomics… Continue Reading

Genomics for the rich: Knome reads your entire genetic code — for the low, low price of $350,000

Genomics for the rich: Knome reads your entire genetic code — for the low, low price of $350,000

(UPDATED: See below.)

(NOTE: This is the first of two posts taking a close look at Knome. For part two, which examines Knome’s business model and how its service works — based largely on an interview with Knome CEO Jorge Conde — see here.)

First it was genomic pioneers… Continue Reading

Life sciences briefing: Wednesday, Nov. 28, 2007

Life sciences briefing: Wednesday, Nov. 28, 2007

Featured companies: American Aerogel, Clinicient, Frazier Healthcare Ventures, Genome Diagnostics, RadPharm, RainDance Technologies, Vivacta

UPDATED: Expanded items on Vitae, RadPharm, Vivacta and Genome Diagnostics. Intelligent Bio-Systems is now covered in a standalone item here.

Vitae Pharma takes in $15M for blood pressure, diabetes drugs — Vitae Pharmaceuticals, a Fort… Continue Reading